跳至主要内容
临床试验/NCT06004362
NCT06004362招募中不适用

Complementary and Integrative Medicine as an Online Intervention in Patients With Post-covid Syndrome - a Randomized-controlled Mixed-methods Trial.

Charite University, Berlin, Germany2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年9月4日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
120
试验地点
2
主要终点
Short Form 36 (SF-36), Physical Functioning Scale

研究概览

简要总结

The Post-COVID syndrome is a COVID-19 sequelae disease with high individual burden. We conduct a prospective, two-arm, randomized-controlled intervention study with embedded qualitative and physiological sub-studies in a mixed-methods design.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Short Form 36 (SF-36), Physical Functioning Scale

时间窗: Baseline, 10 weeks

The scale ranges from 0 to 100, where 0 is the lowest level and 100 is the highest level.

次要结局

  • DePaul Post-Exertional Malaise Questionnaire (DSQ-PEM)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Chalder Fatigue Scale (CFS)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Quality of life (EQ-5D-5L)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Visual analog scale (VAS) physical strength(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Visual analog scale (VAS) mental strength(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Continuation of the intervention(10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • General Self-Efficacy Scale (GSE, German version: ASKU)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Safety by recording adverse events(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Adherence to the study intervention(Week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 9, week 10)
  • Short Form 36 (SF-36)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Visual analog scale (VAS) headache(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Patient Health Questionnaire 9 (PHQ9)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Pittsburgh Sleep Quality Index (PSQI)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Post-COVID-Syndrom (PCS) Score(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Lifestyle questions (diet, alcohol, cigarettes, relaxation, hydrotherapie, nature stays, physical activity)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Expectation regarding study intervention(Baseline)
  • Perceived Stress Scale (PSS 4)(Baseline, 10 weeks, 20 weeks, 30 weeks, 40 weeks, 50 weeks)
  • Satisfaction with the intervention(Week 10)
  • Online diaries for assessing routine care (GP prescriptions/measures, especially medication and phytotherapy/nutritional supplements)(Week 1, week 2, week 3, week 4, week 5, week 6, week 7, week 8, week 9, week 10, week 20, week 30, week 40, week 50)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andreas Michalsen

Principal Investigator

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验